<DOC>
	<DOC>NCT02453152</DOC>
	<brief_summary>This study is a longitudinal study evaluating the severity and progression of respiratory muscle function in patients with X-Linked Myotubular Myopathy (XLMTM) aged 0-14.</brief_summary>
	<brief_title>Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)</brief_title>
	<detailed_description>Subjects aged 0-7 will be evaluated every six months for a total of three evaluations (Baseline, Six-Month Visit, Twelve-Month Visit). Subjects aged 8-14 will be evaluated every twelve months for a total of two evaluations (Baseline, Twelve-Month Visit). Evaluations include medical history, physical exam, respiratory muscle tests, a qualitative interview related to the child's function and use of respiratory aids, and quality of life assessments.</detailed_description>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Myopathies, Structural, Congenital</mesh_term>
	<criteria>Patients who have centronuclear myopathy resulting from an MTM1 genetic mutation. Patients who are between 0 and 14 years of age. Patients without a confirmed genetic mutation. Patients unable to travel to the site for the study. Patients participating in an interventional treatment study for XLMTM at the time of enrollment. Patients who are unable to complete study procedures. Patients who have a condition that, in the opinion of the investigator, would make participation in this study unsafe.</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>myotubular myopathy</keyword>
	<keyword>respiratory muscles</keyword>
	<keyword>natural history</keyword>
</DOC>